Jubilant Pharmova Ltd.’s revenue in Q4FY23 rose 10% to ₹ 1,678 crores. Consolidated Loss After Tax came at ₹ 101 crores in Q4FY23.
Jubilant Pharmova Q4FY23; Reported Losses
Tags: Radiopharma
Related Post
- ASTRAL Q3 FY26 Earnings Results
Astral Ltd maintained stable profitability in Q3 FY26 despite matched revenue-expense growth in plumbing and…
-
Shree Renuka Sugars Q3 FY26 Earnings Results
Incorporated in 1995, Shree Renuka Sugars Ltd does manufacturing and refining of sugar, ethyl alcohol,…
-
Kolte Patil Q3 FY26 Earnings Results
Company is in real estate business (Residential & Commercial) with dominant presence in the Pune…